Lymph node status is a critical factor to predict outcomes and identify patients eligible for chemotherapy. Although histopathology based on H&E is a standard method for lymph node analysis, 30 % of patients diagnosed with negative lymph nodes develop recurrences, likely due to undetected metastases.
File type:
pdf
File size:
156 KB
Release:
26-02-21
